Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

PlanDefinition: PlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.16

Official URL: https://fevir.net/resources/PlanDefinition/179468 Version: 1.0.0-ballot
Active as of 2024-04-27 Computable Name:
Other Identifiers: FEvIR Object Identifier: 179468

Usage:Evidence Communication: RecommendationPlan

Copyright/Legal: https://creativecommons.org/licenses/by-nc-sa/4.0/

8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A

Generated Narrative: PlanDefinition

Resource PlanDefinition "179468" Version "5" Updated "2023-11-24 19:34:38+0000"

Profile: RecommendationPlan

url: https://fevir.net/resources/PlanDefinition/179468

identifier: FEvIR Object Identifier/179468

version: 1.0.0-ballot

title: PlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.16

type: ECA Rule (PlanDefinitionType#eca-rule)

status: active

subject: Group/32139: Bariatric Surgery Eligibility Group (ADA Recommendation 8.16) "Bariatric_Surgery_Eligibility_Group_ADA_Recommendation_8_16"

date: 2024-04-27 20:42:39+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description: 8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A

UseContexts

-CodeValue[x]
*Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication')RecommendationPlan (Evidence Based Medicine on FHIR Implementation Guide Code System#RecommendationPlan)

jurisdiction: World (m49.htm#001)

copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/

author: Brian S. Alper:

RelatedArtifacts

-TypeCitation
*cite-asPlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.16 [PlanDefinition]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179468. Revised 2023-11-24. Available at: https://fevir.net/resources/PlanDefinition/179468. Computable resource at: https://fevir.net/resources/PlanDefinition/179468.

Actions

-TextEquivalent
*Metabolic surgery is recommended.